A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Clinical trial NCT01844180 · COMPLETED

Trial details

NCT number: NCT01844180
Sponsor: Ono Pharma USA Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome (IBS)

Start date: 2013-04-01
Primary completion: 2014-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.